A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study

MLA

Kenneth A. Ellenbogen, et al. “A Placebo-Controlled Trial of Continuous Intravenous Diltiazem Infusion for 24-Hour Heart Rate Control during Atrial Fibrillation and Atrial Flutter: A Multicenter Study.” Journal of the American College of Cardiology, vol. 18, no. 4, Oct. 1991, pp. 891–97. EBSCOhost, https://doi.org/10.1016/0735-1097(91)90743-s.

APA

Kenneth A. Ellenbogen, David M. Mirvis, Vance J. Plumb, Virgil C. Dias, & J. Thomas Heywood. (1991). A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study. Journal of the American College of Cardiology, 18(4), 891–897. https://doi.org/10.1016/0735-1097(91)90743-s

Chicago

Kenneth A. Ellenbogen, David M. Mirvis, Vance J. Plumb, Virgil C. Dias, and J. Thomas Heywood. 1991. “A Placebo-Controlled Trial of Continuous Intravenous Diltiazem Infusion for 24-Hour Heart Rate Control during Atrial Fibrillation and Atrial Flutter: A Multicenter Study.” Journal of the American College of Cardiology 18 (4): 891–97. doi:10.1016/0735-1097(91)90743-s.